Abstract | PURPOSE: To describe two patients with Behçet's disease who underwent cataract surgery one week after infliximab administration. METHODS: RESULTS: There were no intraoperative complications. Neither ocular inflammatory attacks nor infectious complications were found in the operated eyes of both patients during follow-up. CONCLUSION: Administration of infliximab one week before cataract surgery is safe and effective for patients with Behçet's disease.
|
Authors | Tsuneaki Handa, Hinako Tsunekawa, Masahiro Zako |
Journal | Case reports in ophthalmology
(Case Rep Ophthalmol)
Vol. 2
Issue 2
Pg. 176-8
(May 2011)
ISSN: 1663-2699 [Electronic] Switzerland |
PMID | 21720532
(Publication Type: Case Reports)
|